1. Home
  2. FAT vs BCAB Comparison

FAT vs BCAB Comparison

Compare FAT & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FAT Brands Inc.

FAT

FAT Brands Inc.

HOLD

Current Price

$0.40

Market Cap

25.4M

ML Signal

HOLD

Logo BioAtla Inc.

BCAB

BioAtla Inc.

HOLD

Current Price

$0.67

Market Cap

71.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAT
BCAB
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
71.6M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
FAT
BCAB
Price
$0.40
$0.67
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$10.00
$1.00
AVG Volume (30 Days)
564.7K
1.2M
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$574,143,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.24
52 Week High
$6.17
$1.43

Technical Indicators

Market Signals
Indicator
FAT
BCAB
Relative Strength Index (RSI) 22.77 40.18
Support Level $0.42 $0.74
Resistance Level $0.46 $0.83
Average True Range (ATR) 0.05 0.08
MACD 0.04 -0.01
Stochastic Oscillator 0.94 14.83

Price Performance

Historical Comparison
FAT
BCAB

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

Share on Social Networks: